Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DBV Technologies (DBV)

DBV Technologies
Date:
Sort by:
 Showing the most relevant articles for your search:EU:DBV
DateTimeSourceHeadlineSymbolCompany
25/04/202421:30GlobeNewswire Inc.Combined General Meeting of May 16, 2024EU:DBVDBV Technologies
25/04/202421:30GlobeNewswire Inc.Combined General Meeting of May 16, 2024EU:DBVDBV Technologies
25/04/202421:30GlobeNewswire Inc.Assemblée Générale Mixte du 16 mai 2024EU:DBVDBV Technologies
04/04/202421:43GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024EU:DBVDBV Technologies
04/04/202421:43GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024EU:DBVDBV Technologies
04/04/202421:43GlobeNewswire Inc.Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2024EU:DBVDBV Technologies
08/03/202414:33GlobeNewswire Inc.DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration DocumentEU:DBVDBV Technologies
08/03/202414:33GlobeNewswire Inc.DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2023EU:DBVDBV Technologies
08/03/202414:33GlobeNewswire Inc.DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration DocumentEU:DBVDBV Technologies
07/03/202421:30GlobeNewswire Inc.DBV Technologies fait le point sur ses activités et publie ses résultats financiers de l’année 2023EU:DBVDBV Technologies
07/03/202421:30GlobeNewswire Inc.DBV Technologies Reports Full Year 2023 Financial Results and Business UpdateEU:DBVDBV Technologies
07/03/202421:30GlobeNewswire Inc.DBV Technologies Reports Full Year 2023 Financial Results and Business UpdateEU:DBVDBV Technologies
04/03/202421:30GlobeNewswire Inc.DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024EU:DBVDBV Technologies
04/03/202421:30GlobeNewswire Inc.DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024EU:DBVDBV Technologies
04/03/202421:30GlobeNewswire Inc.DBV Technologies présentera ses résultats financiers pour l’exercice 2023 et fera le point sur ses activités le 7 mars 2024.EU:DBVDBV Technologies
20/02/202421:30GlobeNewswire Inc.DBV Technologies participera au prochain congrès de l’AAAAI 2024EU:DBVDBV Technologies
20/02/202421:30GlobeNewswire Inc.DBV Technologies to Participate in Upcoming AAAAI 2024 CongressEU:DBVDBV Technologies
20/02/202421:30GlobeNewswire Inc.DBV Technologies to Participate in Upcoming AAAAI 2024 CongressEU:DBVDBV Technologies
16/01/202421:30GlobeNewswire Inc.Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFEU:DBVDBV Technologies
16/01/202421:30GlobeNewswire Inc.Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHFEU:DBVDBV Technologies
16/01/202421:30GlobeNewswire Inc.Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFEU:DBVDBV Technologies
04/12/202321:30GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  EU:DBVDBV Technologies
04/12/202321:30GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  EU:DBVDBV Technologies
04/12/202321:30GlobeNewswire Inc.Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 novembre 2023EU:DBVDBV Technologies
09/11/202321:30GlobeNewswire Inc.DBV Technologies annonce les résultats à 2 ans d’EPOPEX, étude de prolongation ouverte de phase 3 en cours de l’étude EPITOPE Viaskin™ Peanut chez les jeunes enfantsEU:DBVDBV Technologies
09/11/202321:30GlobeNewswire Inc.DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in ToddlersEU:DBVDBV Technologies
09/11/202321:30GlobeNewswire Inc.DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in ToddlersEU:DBVDBV Technologies
06/11/202321:30GlobeNewswire Inc.Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023EU:DBVDBV Technologies
06/11/202321:30GlobeNewswire Inc.Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023EU:DBVDBV Technologies
06/11/202321:30GlobeNewswire Inc.Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 31 octobre 2023EU:DBVDBV Technologies
 Showing the most relevant articles for your search:EU:DBV